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Evaluation of a Specialized Oncology Nursing Supportive Care Intervention on Newly 
Diagnosed Breast and Colorectal Cancer Patients following Surgery: A Cluster 
Randomized Trial 
 
BACKGROUND: Better coordination of supportive services during the early phases of cancer 
care has been proposed to improve the care experience of patients. We conducted a randomized 
trial to test a community-based nursing-led coordination of care intervention in cancer patients. 
 
METHODS: Surgical practices were cluster randomized to a control group involving usual care 
practices or a standardized nursing intervention consisting of an in-person supportive care 
assessment with ongoing support to meet identified needs, including linkage to community 
services. Newly diagnosed breast and colorectal cancer patients within 7 days of cancer surgery 
were eligible. The primary outcome was the patient-reported outcome (PRO) of continuity of 
care (CCCQ) measured at 3 weeks. Secondary outcomes included unmet supportive care needs 
(SCNS), quality of life (EORTC QLQ-C30), health resource utilization, and level of uncertainty 
with care trajectory (MUIS) at 3 and/or 8 weeks.  
 
RESULTS: A total of 121 breast and 72 colorectal patients were randomized through 28 surgical 
practices. There was a small improvement in the informational domain of continuity of care 
(difference 0.29 p=0.05) and a trend to less emergency room use (15.8% vs 7.1%) (p=0.07). 
There were no significant differences between groups on unmet need, quality of life, or 
uncertainty. 
 
CONCLUSION: We did not find substantial gaps in the PROs measured immediately following 
surgery for breast and colorectal cancer patients. The results of this study support a more targeted 
approach based on need and inform future research focused on improving navigation during the 





Evaluation of a Specialized Oncology Nursing Supportive Care Intervention on Newly 
Diagnosed Breast and Colorectal Cancer Patients following Surgery: A Cluster 
Randomized Trial 
INTRODUCTION 
The transition from an initial diagnosis of cancer through entry into the formal cancer 
system has been identified as a time of significant emotional distress, physical morbidity, and 
uncertainty for patients.[1-3] Despite efforts to improve transitions in care and reduce waiting 
times for cancer diagnosis and treatments, meeting the supportive care needs of patients and 
families remains a significant challenge.[2,4,5] Newly diagnosed cancer patients report 
discontinuities in their care due to increasingly complex treatments involving multiple providers 
at different locations.[2,4,6-8] We and others have found that discontinuities experienced by 
cancer patients/families can worsen stress and anxiety since they already feel threatened by a 
difficult disease and uncertain future. [5,6,8,9] Indeed, a recent review found that cancer 
patients’ need for informational support to be prevalent, along with emotional care.[10] 
Supportive care issues continue to be a priority area for research and policy in the USA, Canada, 
Australia, and elsewhere, with the aim to lessen the negative burden of care experience.[7,8,11] 
Supportive care to meet the psychological, social, physical (symptom control), 
informational, and practical needs of patients is an essential component of cancer 
treatment.[12,13]. Active coordination of supportive care is proposed as one method to address 
care discontinuity and barriers to accessing these resources, [2,4,5] but evaluations of its 
effectiveness, beyond assessments of patient satisfaction, are lacking.[2,14] In response to the 
recognized gap in patients’ supportive care experience following diagnosis and primary surgical 
treatment, we evaluated a community based nursing-led coordination of care intervention in 
newly diagnosed breast and colorectal cancer patients. The study objectives were to determine 
the effect of the specialized oncology nursing program on continuity of care and unmet needs, as 
well as, on quality of life, uncertainty, and healthcare use, as compared to usual care. We 
hypothesised that an improvement in these outcomes would result at two months after surgery 
among patients receiving support from a specialized oncology nurse, compared to usual care. 
 
ClinicalTrials.gov Identifier: NCT00182234 






This was a prospective cluster randomized trial. Participating surgical practices were 
randomized to usual care (control) or usual care plus a standardized specialized oncology nursing 
supportive care intervention (experimental) using a permuted block design to ensure groups of 
equal sizes. The sequence of allocation was computer-generated and each assignment placed in a 
numbered sealed envelope, which were consecutively opened for each practice recruited. Patient 
participants were accrued through the individual surgical practices in community hospitals (4) or 
teaching hospitals (4) in the Greater Toronto Area (GTA) in Ontario, Canada, and assigned to 
control or experimental arms based on allocation of the practice. This approach was used to 
minimize contamination between arms and simplify the accrual process for surgical practices.  
 
Participants 
The trial included patients with newly diagnosed, histologically confirmed breast or 
colorectal cancer within the initial stages of surgical intervention (immediately post-surgery). 
Other inclusion criteria were: no previous or concomitant malignancies (except: non-melanoma 
skin cancer; carcinoma in situ of the cervix), legally able to provide informed consent, 18 years 
of age or older, and able to speak and read English. Patients had to reside in the intervention 
program catchment area corresponding to the GTA. Ethical approval to conduct the study was 
obtained from the hospitals from which surgeons recruited patients. 
 
Intervention 
The intervention consisted of usual care plus referral to a standardized specialized 
oncology nurse service provided by the Interlink Community Cancer Nurses (ICCN) program in 
Toronto. ICCN was an established program of nurse-led clinical case coordination [15]. This 
service was structured around four program components: (i) direct oncology nursing practice; (ii) 
coordinated mobilization and linkage to services; (iii) community-based education and research; 
and (iv) community resource development [16]. The program was provided by five registered 
nurses, overseen by a nurse manager. Most of these nurses were Masters prepared; all were 
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certified in Oncology Nursing (CON(C)) with a minimum of four years specialty cancer 
experience.  
ICCN is modeled after the Macmillan nurse program in the United Kingdom, which 
provides expert advice and support to patients and families with cancer and health care 
professionals through home visiting and telephone support [15-18]. The ICCN model was 
intended to follow a tailored approach to care based on a comprehensive assessment of each 
patient’s needs, care requirements and wishes [15]. The nurses did not provide medical care but 
information and emotional support, as well as coordinating and navigating access to other needed 
supportive cancer care services. [15-18] Emotional care by ICCN nurses included supportive 
care techniques like active listening, clarification, explanation and education, and guidance in 
coping/managing the effects of cancer [15,17]. 
ICCN employed a Standardized Nursing Intervention Protocol (SNIP) for the nurses to 
follow. This protocol included comprehensive assessment, information and emotional support, 
and care planning specific to breast and colorectal cancers during the initial phases of treatment, 
with a minimum of two home visits. A training session was held with the Interlink nurses prior to 
the study commencing to ensure consistency in providing supportive care tailored to this phase 
of care and in the timing of intervention follow-up. ICCN is previously described in further 
detail, including a logic model of the intervention.[16,19] 
 
Recruitment and Data Collection 
Following randomization, each participating surgical practice received on-site training in 
patient accrual for their particular arm of the study. All consecutive eligible patients were 
identified by the surgeons’ practices at the pre-surgery consultation. Contact, eligibility, and 
surgery date information for these patients, with their permission, was immediately faxed to the 
research office. Trained interviewers, blinded to study allocation, collected patient reported 
outcomes (PROs) via telephone interviews administered at 3 time points in their care trajectory, 
specifically, 2 to 7 days post hospital discharge from surgery (T1 [baseline]), 2 to 3 weeks after 
baseline (T2), and 8 to 10 weeks after baseline (T3).  
Patients in the intervention group were referred to the ICCN intervention following 
baseline completion. Data were collected from ICCN logs on the number and type (e.g., phone, 
home visit, etc.) of contacts made with each study patient to measure and ensure compliance 
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with the intervention prior to the second (T2) and third (T3) interviews. The second interview 
was intended to occur two weeks after the intervention had begun and was not completed until at 
least one home visit had been made. The names of control group patients were checked with 
ICCN administration data to ensure that they had not accessed the intervention. 
 
Outcomes 
The primary outcome was the mean subdomain scores of the Continuity of Care 
Questionnaire (CCCQ) at T2.[19,20] Continuity of care and service utilization was not measured 
at baseline (T1) because community services had not been initiated. Secondary outcomes were 
the change from baseline to T2 in the domain scores of the Supportive Cancer Need Survey 
(SCNS-SF34), [21,22] the European Organization for Research and Treatment of Cancer Quality 
of Life Questionnaire Version 3.0 (EORTC QLQ-C30), [23] the Mishel Uncertainty in Illness 
Scale-Community Form (MUIS-C) score, [24] and a self-reported health care utilization survey. 
Comparisons were also made between change scores from baseline to T3 to examine change 
over this period of time (8 to 10 weeks). 
The CCCQ measures continuity of care and was adapted specifically for a community-
based oncology setting from the Components of Primary Care Index (CPCI) [20] and previously 
validated in our cohort study of the ICCN program [19]. The instrument asks respondents to rate 
their experience in four domains of continuity of care: relational, informational, management, 
and preference for the same health care provider.  
The SCNS-SF34 evaluates supportive needs in five domains: Psychological Needs; 
Health System and Information Needs; Physical and Daily Living Needs; Patient Care and 
Support Needs; and Sexuality Needs. [21,22] The MUIS-C measures four domains of 
uncertainty: Ambiguity; Complexity; Inconsistency; and, Unpredictability.[24] This instrument 
has been used extensively in patients with breast cancer and other malignancies. 
Service utilization was captured using an instrument developed for the study containing 
an inventory list of available community services and a review of other similar instruments.[25] 
Participants were asked which of these services they used in the given time, frequency of use, 





Previous work using the CCCQ with cancer patients identified a mean score of 3.65 for 
each domain and a standard deviation (SD) of 0.85 (scale from 1 to 5). We assumed that a 
difference of 0.6 in SD (i.e., a delta of 0.5 or a half point on the scale) between treatment groups 
at T2 would be important to detect [18]. Accounting for the cluster design, we estimated that the 
correlation between patients within surgical practices was 0.15 and that each surgeon would see 
an average of 6 eligible patients. Given a two-sided alpha of 0.05, a power of 80%, and a drop-
out rate of 10%, 182 patients from 28 surgical practices was required.  
 
Statistical Methods 
Instrument scores for the CCCQ, SCNS, MUIS, and EORTC QOL-30 were calculated 
and analyzed based on scoring guidelines for these validated instruments (see Table 2 for scale 
ranges). A two-sample t-test adjusting for the increased variance due to clustering was used to 
compare the means of primary and secondary outcomes between intervention and control groups 
[26]. Confidence intervals (CI) for the difference of means were adjusted for data clustering. 
Multilevel mixed models with two levels, cluster and repeated measures were used to investigate 
the effect of intervention over time on the CCCQ, SCNS, MUIS, and EORTC QOL-30. 
Service utilization data from the two time points (T2 and T3) were combined to create a 
time span of up to 10 weeks from baseline. Usage of individual types of services was 
summarized using frequencies and means. Mixed models adjusting for clustering were used to 
compare the number of patients who reported using each service. Data were analyzed using SAS 
9.2 (SAS Institute Inc., Cary, NC). 
 
RESULTS 
Surgical practice recruitment and patient flow are presented in Figure 1. Of 35 practices 
randomized, 28 recruited patients during the study period: 13 of these practices were allocated to 
the intervention arm and 15 practices to the control arm. The intervention and control arm 
allocated practices had similar characteristics (e.g., surgeon sex, years of practice, solo vs group). 
Practices were open to patient accrual for up to three years or until 14 patients were accrued from 
the practice. Each practice accrued an average of 10 patients to the study. 
Of the 244 patients who met the study eligibility criteria, 193 (79%) consented to 
participate in the study, 104 in the control group and 89 in the intervention group. Of these 
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patients, 186 (96%) completed a T2 survey and 180 (93%) completed a T3 survey. Patient 
groups were similar with respect to baseline characteristics such as age, sex, disease site, marital 
status, and income (Table 1). Patients in the intervention had a median of 6 ICCN nursing 
contacts (telephone or visit) up to T3 and mean of 2.2 home visits (median = 2, range = 1 to 6, 
SD = 1.1). The most common activities reported delivered to patients by the ICCN nurses were 
comprehensive health assessment (94% of patients), health teaching and coaching (88%), 
ongoing re-assessments (55%), emotional support (52%), and symptom management (27%). 
Outcome scores are presented in Table 2. Borderline significant improvement was seen in 
informational continuity (CCCQ) in the intervention group compared to the control group at T2 
(difference=0.29; 95% CI: 0.00 to 0.48; p=0.05) but little difference was found in the other 
continuity subdomains. Sensitivity analysis using multiple imputation to account for patients lost 
to follow-up showed similar results. At baseline, 20.2% of the study cohort reported high (mean 
 4) unmet need in at least one SCNS subdomain, with intervention group patients reporting 
slightly higher needs at this time point. Level of need decreased in both groups over time, 
slightly more in the intervention group for all factors except “Patient care & support”, but did not 
reach significance.  
The uncertainty of illness (MUIS) mean change scores did not differ significantly 
between groups (difference=-1.19; 95% CI: -5.16 to 2.78; p=0.56), as neither did the quality of 
life (EORTC QOL-30) mean change scores. No additional effects were found at T3 for any of 
the outcomes (all intervention by time interaction p-values > 0.05). Health service utilization, 
including hospitalization, and visits to primary care physicians, specialists, allied health 
professionals, and other community services did not differ between groups (Table 3). Twice as 
many patients in the control group visited emergency departments in the 10 week study time 
compared to those receiving the intervention (15.8% vs 7.1%), however this trend did not reach 
significance (p=0.07).  
 
DISCUSSION 
Prior literature has reported that cancer patients across the trajectory of care experience 
inadequate pain management, psychological burden, and other unmet supportive care needs 
partially due to poor continuity and access to community resources.[2,11,27] We used a rigorous, 
clustered RCT design, that incorporated validated instruments appropriate to the measurement of 
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patient navigation interventions, [28] to assess the impact of the ICCN program on PROs for 
newly diagnosed breast or colorectal cancer patients at the post-surgical period. We found a 
small improvement in information continuity at two weeks (T2) in the intervention group. 
Overall, the level of unmet supportive care needs, quality of life, and uncertainty of illness 
improved over time (0 to 10 weeks) in both study groups. This effect appeared greater in the 
intervention group for many of these PROS, but no difference was detected in change scores 
between study groups. Although no significant differences were found in self-reported 
utilization, we did observe a trend to less emergency room use in the experimental group.  
While there have been several trials assessing oncology nurse-led supportive care, 
[14,29-33] this study is the first trial to specifically examine care coordination and unmet need in 
the period immediately following cancer surgery. Two recent reviews on the effects of distress 
screening/triage interventions for psychosocial unmet needs on cancer PROs had mixed findings, 
with many trials showing no positive effect likely due to being underpowered and possible 
contamination between study arms [34,35]. Similar to our study, many trials reported 
improvement in PROs overtime regardless of study arm [27,33,36] and some found post-surgery 
cancer patients had low levels of unmet need at baseline.[31,36] 
This study was conducted in Canada with a universally funded healthcare system that 
has, as its backbone, a strong primary care structure. Over 90% of the participants in the study 
had an identified primary care provider. It is likely that the baseline level of care coordination 
was higher than in populations previously reported in the literature that did not have consistent 
access to primary care.[11,32] This propensity is reflected in our findings of both groups (76%) 
reporting contacting their primary care provider over the study period. The self-reported health 
service utilization patterns did suggest a tendency toward the use of more supportive care 
services in the intervention group, although these differences did not reach significance. The 
baseline scores in both the experimental and control groups on unmet need were lower than 
previously reported in the literature [21,37] and continuity of care at 4 weeks was higher, 
limiting the range of change that could be captured over time. It would be valuable to test 
supportive care interventions in health systems that do not provide comprehensive universal 
primary care.  
Some have argued for screening to identify higher need individuals to target supportive 
care interventions towards those who may derive the most benefit.[22,38] Trials of targeted 
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oncology nurse-led interventions including patient education, skills training, and counselling 
specifically for patients with poorly controlled pain found reductions in patient-related barriers to 
self-management of cancer pain and pain intensity, compared to usual care.[29,30] Our study 
included only a small number of respondents in the highest quartile of unmet need and therefore 
lacked the power for a subgroup analysis of these high need patients. Further study of targeted 
nursing interventions in high need populations is warranted. 
A number of other study limitations need to be considered. While we used the most 
rigorously tested continuity of care scale available at the time, [39] this instrument may lack 
sensitivity over relatively short periods of time during care transitions. We chose continuity of 
care as the primary outcome given our previous work of ICCN program [16,19].  However, it 
may not have been a sensitive outcome and less relevant during this pre-treatment phase, 
particularly since 80% of the cohort did not report a high supportive care need at baseline. The 
cluster design of our trial was important to support recruitment and reduce contamination, but 
reduced the power of our study to detect small effects. It could be argued that a small change 
observed using a less conservative design may still not be clinically relevant, considering the 
resources required to deliver this type of intervention. Finally, it is also important to note that 
patient navigation was not a planned component of the nursing intervention that we studied, in 
that navigation programs typically follow patients from the onset of cancer-related care, i.e., 
abnormal screening result. As such, we cannot draw inferences from our data as to the efficacy 
of cancer patient navigation on the diagnostic care experience, optimizing cancer care 
trajectories, or reducing unnecessary waits for transition to oncology care, demonstrated in other 
studies.[40] 
Distress screening at the time of initial oncology assessment is essential to address patient 
needs [35,41]. Our findings suggest that interventions such as the ICCN program to supplement 
usual care around the time of initial surgical treatment may provide supportive care benefits. Our 
results are generalizable within health care systems that provide universal access for breast and 
colorectal cancer patients, who make up a significant proportion of newly diagnosed patients. 
Furthermore, our finding of low levels of unmet need supports the use of systematic screening to 
identify populations most likely to benefit from targeted supportive care interventions. The trend 
observed towards less acute care utilization calls for ongoing research into the role of system 
navigation, particularly during care transitions. Future research of system navigation should 
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include PROs, such as those used in this study, to better understand impact on different aspects 
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